These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9013471)

  • 21. Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.
    Sulkes A; Smyth J; Sessa C; Dirix LY; Vermorken JB; Kaye S; Wanders J; Franklin H; LeBail N; Verweij J
    Br J Cancer; 1994 Aug; 70(2):380-3. PubMed ID: 7914428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer].
    Inuyama Y; Kataura A; Togawa K; Saijo S; Satake B; Takeoda S; Konno A; Ebihara S; Sasaki Y; Kida A; Kanzaki J; Ichikawa G; Kono N; Moriyama H; Kamata S; Miyake H; Sakai M; Horiuchi M; Kubota A; Tsukuda M; Matsuura H; Baba S; Saito H; Matsunaga T; Taguchi T
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):107-16. PubMed ID: 9987506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer.
    Shapiro JD; Millward MJ; Rischin D; Davison JD; Michael M; Francis PA; Ganju V; Toner GC
    Aust N Z J Med; 1997 Feb; 27(1):40-4. PubMed ID: 9079252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
    Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
    Eur J Cancer; 2001 Oct; 37(15):1833-8. PubMed ID: 11576836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Forsyth P; Cairncross G; Stewart D; Goodyear M; Wainman N; Eisenhauer E
    Invest New Drugs; 1996; 14(2):203-6. PubMed ID: 8913841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of docetaxel in advanced soft tissue sarcomas.
    Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
    Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma.
    Sinibaldi VJ; Carducci MA; Moore-Cooper S; Laufer M; Zahurak M; Eisenberger MA
    Cancer; 2002 Mar; 94(5):1457-65. PubMed ID: 11920502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.
    Bedikian AY; Weiss GR; Legha SS; Burris HA; Eckardt JR; Jenkins J; Eton O; Buzaid AC; Smetzer L; Von Hoff DD
    J Clin Oncol; 1995 Dec; 13(12):2895-9. PubMed ID: 8523052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
    Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
    Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.
    McCaffrey JA; Hilton S; Mazumdar M; Sadan S; Kelly WK; Scher HI; Bajorin DF
    J Clin Oncol; 1997 May; 15(5):1853-7. PubMed ID: 9164195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.
    van Hoesel QG; Verweij J; Catimel G; Clavel M; Kerbrat P; van Oosterom AT; Kerger J; Tursz T; van Glabbeke M; van Pottelsberghe C
    Ann Oncol; 1994 Jul; 5(6):539-42. PubMed ID: 7918126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of docetaxel (Taxotere) for untreated advanced colorectal carcinoma.
    Clark TB; Kemeny NE; Conti JA; Huang Y; Andre AM; Stockman J
    Cancer Invest; 1998; 16(5):314-8. PubMed ID: 9627678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
    Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
    Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.
    Ravdin PM; Burris HA; Cook G; Eisenberg P; Kane M; Bierman WA; Mortimer J; Genevois E; Bellet RE
    J Clin Oncol; 1995 Dec; 13(12):2879-85. PubMed ID: 8523050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel.
    Chen YM; Shih JF; Lee CS; Chen MC; Lin WC; Tsai CM; Perng RP
    Lung Cancer; 2003 Feb; 39(2):209-14. PubMed ID: 12581575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
    Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
    Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy.
    Chan S
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):19-24. PubMed ID: 9364537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II open-label study of DHA-paclitaxel (Taxoprexin) by 2-h intravenous infusion in previously untreated patients with locally advanced or metastatic gastric or oesophageal adenocarcinoma.
    Jones RJ; Hawkins RE; Eatock MM; Ferry DR; Eskens FA; Wilke H; Evans TR
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):435-41. PubMed ID: 17440725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
    Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
    Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.